This post was just published on ZYX Buy Change Alert. BLCM is long with an average price of $19. As of this writing it is trading at $25.84. Consider taking profits on a 20% tranche in the zone of $25 to $26.73. Also consider stops on a 20% tranche in the
This post was published on ZYX Buy Change Alert. JUNO is developing immunotherapies for lymphomas, leukemias and other cancers. It is an upcoming IPO This is a call to buy in the IPO at the IPO price. To be clear, this is not a call to buy the stock post IPO
This post was published on ZYX Buy Change Alert. BLCM is a clinical stage biopharmaceutical company focused on discovering and developing novel cellular immunotherapies for various forms of cancer, including both hematological cancers and solid tumors, as well as orphan inherited blood disorders. It is an upcoming IPO This is a
This post was just published on ZYX Buy Change Alert. RAD is long from an average of $4.96 and 70% of the full core position size is being held. In the premarket as of this writing RAD is trading at $6.72. Consider taking profits on a 10% tranche in the zone